(PDF) The prophylactic treatment of pulsed electromagnetic field (PEMF) in the refractory migraine headache, double-blind, parallel placebo-controlled study

FINAL SCIENTIFIC PROGRAM

CHAIRMEN

Prof. Mohammed Saadah (UAE)

Prof. Valery Feigin (NZ)

Jumeirah Etihad Towers Hotels

ACM.MND.13.10.01 - © William Beaucardet / PWP

FIGHTING STIGMA TRAINING HEALTHCARE

PROFESSIONALS

DEVELOPING ACCESS TO CARE IN EPILEPSY

Sanofi is strongly committed to improving access to care for patients with

epilepsy in developing countries. Programs are being implemented in Africa,

Asia and Latin America through partnerships bringing together stakeholders

from different sectors. These programs are focused on educating communities

and fighting stigma, training healthcare professionals to diagnose and manage

epilepsy, and making medicines accessible to the poorest patients through

tiered pricing policies. csr.sanofi.com

TIERED PRICING POLICY

FOR MEDICINES

ACM-MND-13-10-01 Ad A4.indd 1 17/10/13 09:49

Dear colleagues and friends,

We are very happy to welcome you to the 3rd ICNE, in Abu Dhabi.

Like previous ICNE congresses, this Congress features internationally recognized invited

speakers, platform lectures, oral presentations and poster sessions, and will provide an ideal

platform for continuing education in all ﬁelds of experimental and non-experimental clinical

neurology and epidemiology. As such, the International Congress will provide an excellent

opportunity for the nearly 500 attendees, of whom neurologists, neurosurgeons, epidemiologists,

neuropsychologists, rehabilitation specialists, geriatricians, family physicians, nurses, aged care

specialists and health care providers working in the area of neurological disorders to share their

new ideas, research ﬁndings and experience.

We hope this congress will match all your expectation and take this opportunity to thank all our

partners, without whom nothing would have been possible.

Enjoy a great scientiﬁc program and a great city!

Prof. Mohammed Saadah

Congress President

Prof. Valery Feigin

Congress Chairman

World Federation for

NeuroRehabilitation

World Federation of

Neurology

World Stroke

Organization

World Parkinson’s

Education Program

ENDORSEMENTS

Ettore Beghi, Italy

Michael Brainin, Austria

Dominique Cadilhac, Australia

Stephen Davis, Australia

Valery Feigin - Chairman, NZ

Maurice Giroud, France

Werner Hacke, Germany

Arfan Ikram, The Netherlands

Elan Louis, USA

Man Mohan Mehndiratta, India

Walter Rocca, USA

Mohammed Saadah - Président, UAE

Ralph Sacco, USA

Yukito Shinohara, Japan

Amanda Thrift, Australia

PROGRAM COMMITTEE

Gururaj Aithala, UAE

Mohammed AlKaylani - Vice Chairman, UAE

Andrey Alexandrov, USA

Sarmad Alfahad, UAE

Numan Amir, UAE

Bruce Arroll, NZ

Kjell Asplund, Sweden

Michael P. Barnes, UK

Daniel Bartko, Czech Republic

Jeffrey R. Basford, USA

David A. Bennett, USA

Derrick Bennett, UK

Gudrun Boysen, Denmark

Carol Brayne, UK

Monique Breteler, NL

Allen W.M.D. Brown, USA

Yury Bykov, Russia

Dominique Cadilhac, Australia

Honglei Chen, USA

Antonio Culebras, USA

J-François Dartigues, France

Jacques L. De Reuck, Belgium

Geoffrey Donnan, Australia

Bruno Dubois, France

Mohamed ElTamawy, Egypt

Alexis Elbaz, France

Majid Ezzati, USA

Cristian Falup Pecurariu, Romania

Cesare Fieschi, Italy

James Fisher, USA

Marek R. Graczynski, Poland

Anders Grisold, Sweden

Evgenii I. Gusev, Russia

Anthony Hannan, Australia

Hans-Peter Hartung, Germany

Kris Heggenhougen, USA

Michael G. Hennerici, Germany

Albert Hofman, NL

Wolfgang Jonannson, UAE

Kelly Jones, NZ

Saadat Kaman, Qatar

Pavel Kalvach, Czech Republic

Jürg Kesselring, Switzerland

Carlos N. Ketzoian, Uruguay

Lyad Khoudeir, UAE

Brett Kissela, USA

Miia Kivipelto, Sweden

Detlef Kömpf, Germany

Amos D. Korczyn, Israel

Rita Krishnamurthi, NZ

Ajit Kumar, UAE

Prem Kumar Sinha, UAE

Liping Liu, China

Giancarlo Logroscino, Italy

Hugh Markus, UK

Alexandra Martiniuk, Australia

Michael Y. Martinov, Russia

Ian McDowell, Canada

Man Mohan Mehndiratta, India

George Mensah, USA

Liu Ming, China

Khaldoun Mozahem, UAE

Christopher Murray, USA

Ken Nagata, Japan

Kenji Nakashima, Japan

David Neary, UK

Jean-Marc Orgogozo, France

Jeyaraj Durai Pandian, India

Kameshwar Prasad, India

Shireen Qureshi, SA

Abdul Qayyum Rana, Canada

Gabriel Rinkel, NL

Kenneth Rockwood, Canada

Gustavo C. Roman, USA

Peter Rothwell, UK

Mohammed Saadah - President, UAE

Ahmed Sameer, UAE

Peter Sandercock, UK

Giovanni Savettieri, Italy

Omar Shafey, UAE

Mostafa Shaqra, UAE

Peter Spencer, USA

Jan Staessen, Belgium

Con Stough, Australia

Il Suh, South Korea

Tania Tayah, UAE

Bruce Taylor, Australia

Alice Theadom, NZ

Amanda Thrift, Australia

Jaakko Tuomilehto, Finland

Christophe Tzourio, France

Hirotsugu Ueshima, Japan

Ingrid Van Der Mei, Australia

Jan Van Gijn, NL

Chong Victor, UK

Demarin Vida, Croatia

Hans Von Holst, Sweden

Sahabat Asim Wasti, UAE

David Wiebers, USA

Charles Wolfe, UK

SCIENTIFIC ADVISORY COMMITTEE MEMBERS

www.icne2013.com

Shareefa Abdool - Vice President, Rashid Hosp.

Wafa Adhami, HAAD

Khalid AlJaberi, HAAD

Mohammed AlKaylani, Tawam Hosp.

Tawﬁq AlSaadi, Sheikh Khalifa Medical Centre

Khalid AlShamsi - Vice President, Saqer Hosp.

Kassem AlShunnar, Neurosurgery, American Hosp.

Numan Amir, Sheikh Khalifa Medical Centre

Mahfoud Y. ElBashari, Military Hosp.

Imad Hashim, Neurosurgery, Rashid Hosp.

Deeb Kayed, Private Practice

Ajith Kumar, Mafraq Hosp.

Prem Kumar Sinha, Zulaikha Hosp.

Shireen Qureshi, Saudi ARAMCO

Ayyanar Rajarathinam, Private Practice

Abdul Qayyum Rana, Parkinson’s Clinic of Eastern Toronto

Mohammad Saadah, President, Zayed Military Hosp.

Ahmed Sameer, Rashid Hosp.

Omar Shafey, HAAD

ORGANIZING COMMITTEE

Shareefa Abdool - Chairman, Rashid Hosp.

Tareq Aﬁﬁ - Vice Chairman, Zayed Military Hosp.

Khalid AlBaghdadi, Private Practice

Ali AlBar, Private Practice

Nazar Ibrahim AlDoori, Tawam Hosp.

Sarmad AlFahad, Neurospinal Hosp.

Firas AlRawi, Private Practice

Khalid AlSaffar, Private Practice

Sarmad AlShammaa, Neurospinal

Siarhei Bahushevich, Royal Hosp.

Sharmila Changkakoti, Private Practice

Vinod Choondal, Al Baraha Hosp.

Mohamed ElHadi, Tawam Hosp.

Waseem Fathallah, Al Mafraq Hosp.

Atta Ghassan , Al Ain Hosp.

Lucky Gupta, Private Practice

Hamid Reza Haghighat, Irani Hosp.

Hareth Hamdan, Private Practice

Suzan Ibrahim - Vice Chairman, Rashid Hosp.

Mohammed Ismail, Private Practice

Denish Jacob , Private Practice

Nayak D. Kotekar, Kuwaiti Hosp.

Sasi Kumar, Private Practice

Qamar Mirza, Private Practice

Khaldoun Mozahem, Private Practice

Nagi Moussa, Al Ain Hosp.

Suresh Naryanan, Gemmy Hosp.

Kasid Noori, WelCare Hosp.

Taleb Abdul Rahim, Private Practice

SP. Rajendran, Private Practice

Mohammed Tawﬁq Ridha, Saqer Hosp.

Ahmad Shahwan, Private Practice

Amin Shawabkeh, Private Practice

Miklos Szolics, Tawam Hosp.

Tayseer Zain, Al Qasemi Hosp.

LOCAL ADVISORY COMMITTEE

Wafa Adhami - Vice Chairman, HAAD

Khalid AlBaghdadi, Private Practice

Nazar Ibrahim AlDoori - Vice Chairman, Tawam Hosp.

Firas AlRawi, Private Practice

Lucky Gupta, Private Practice

Suzan Ibrahim, Rashid Hosp.

Qamar Mirza, Private Practice

Nagi Moussa, Al Ain Hosp.

Mohammed Tawfiq Ridha - Chairman, Saqer Hosp.

SOCIAL COMMITTEE

Ammar AlKawi, KSA

Zuhair AlKawi, KSA

Nagi AlRiyashi, Lebanon

Abdul Rahman AlTahan, KSA

Mohd AlTamawi - Chairman, Egypt

Adel Aljishi, Bahrain

Asmahan AlShubaili, Kuwait

Ahmed Beydoun, Lebanon

Riadh Gouider - Vice Chairman, Tunis

Saher Hashem, Egypt

Ahmad Khalifa - Vice Chairman, Syria

Walid Khoja, KSA

Boulenouar Mesraoua, Qatar

Ammar Mobayyedhin, Jordan

Mohamed Wasay, Pakistan

NATIONAL ADVISORY COMMITTEE

www.icne2013.com

COMMITTEES

>> Room 1

08:00 Registration Opens

09:00-09:50 Workshops - Part 1:

Workshop on sleep disorders (K. Mozahem, UAE)

09:50-10:30 Coffee-break and visit of the exhibition and posters area

10:30-12:10 Workshops - Part 2:

Diagnostic imaging of the central nervous system with ultrasound (W. Jonannson, UAE)

How to write a scientiﬁc article? (V. Feigin, NZ)

12:10-13:30 Lunch Break, visit of the exhibition and posters area

13:30-15:00 Opening ceremony

- Mohammed Saadah, Local Chairman of the congress

- Valery Feigin, Chaiman of the congress

- Royal greeting

- Sheikh Sultan Ben Neheyan, Abu Dhabi's Rep.

15:00-15:30 Keynote lecture 1

Global burden of neurological disorders: updates from the Global Burden of Disease 2010 Project (C. Murray, USA)

15:30-16:00 Keynote lecture 2

The coming NCD-Crisis: How well are we prepared to cope with it? (W. Hacke, Germany)

16:00-17:00 Plenary Session 1 - Part 1: Stroke epidemiology, prevention and management - Chairmen: W.Wasay, D. Cadilhac

Challenges in stroke research in low to middle income countries (A. Thrift, Australia)

Epidemiology of stroke in South Asia (M. Wasay, Pakistan)

Implementing thrombolysis on a nationwide level (W. Hacke, Germany)

17:00-17:30 Coffee-break and visit of the exhibition and posters area

17:30-18:30 Plenary Session 1 - Part 2: Stroke epidemiology, prevention and management - Chairmen: N. Amir, D. Cadilhac

Management of acute stroke: updates (N. Amir, UAE)

Difﬁculties in measuring stroke rehabilitation and adherence to best practice: an example from Australia (D. Cadilhac, Australia)

Secondary Stroke Prevention (N. Amir, UAE)

Hypertension management and the evaluation of the performance in primary health care in New Zealand (B. Arroll, NZ)

THURSDAY NOVEMBER 21, 2013

FINAL SCIENTIFIC PROGRAM

>> Room 2

16:00-17:00 > Prevention * - Chairmen: D. Bartko, R. Alowesie

01.100 Predictors of Outcome in Gunshot Wounds of the Head (B. Aarabi)

01.146 Fascinating new era. Atherosclerosis is vascular inﬂammatory disease (D. Bartko)

01.148 Asymptomatic carotid stenosis. What is the best approach? Cea and or cas?

Or recently prefered medical prevention ? Critical overview (D. Bartko)

01.153 Carotid intima-media thickness in parkinson’s disease patients with dyskinesia (G.A. Shahidi)

01.192 Anxiety and Depression correlates in Saudi victims of Spinal Cord Injury (R. Alowesie)

01.259 Epidural Hematomas In Paddle Spinal Cord Stimulators (N. Moufarrij)

17:00-17:30 Coffee-break and visit of the exhibition and posters area

17:30-19:00 > Diagnosis * - Chairmen: A. Karch, H. Al-Jehani

02.166 A matter of applying appropriate diagnostic criteria – why we might underestimate the incidence

of Creutzfeldt-Jakob disease in the very old (A. Karch)

02.180 Aetiological factors and precipitants of epileptic seizures in Nigerian Africans- hospitals-based study

from Kaduna State, Northern Nigeria (O. Obiako)

02.256 TCD in cerebral reversible vasoconstrictive syndrome associated with elevated intracranial pressure, a novel ﬁnding (H. Al-Jehani)

02.260 Seronegative longitudinal extensive transverse myelitis in Korean Males+ is it related with toxocariasis? (K.H. Lee)

02.297 DSM-5 the New Diagnostic System in North America- Evolution and Epidemiological Applications (J. Escobar)

02.394 Validation of the arabic rowland universal dementia assessment scale (rudas) in elderly with mild and moderate dementia (M. Chaaya)

02.452 Blink Reﬂex and brain death (R. Zaidan)

02.454 Assessment of pathogenic SAPs in HEXA and HEXB gene using publically available in silico tools - A roadmap

for neuroepidemiologists (G. Priya Doss C)

* Presenting speakers only. See abstract book for the complete list of authors

FRIDAY NOVEMBER 22, 2013

FINAL SCIENTIFIC PROGRAM

>> Room 1

07:00-08:00 Interactive session - Chairmen: E. Beghi, Y.Shinohara

Juvenile Myoclonic Epilepsy- is it truly benign? (E. Beghi, Italy and M.M. Mehndiratta, India)

Controversies in epilepsy management (E. Beghi, Italy)

Controversies in the primary prevention of CVD (B. Arroll, NZ)

08:00-9:00 Plenary Session 2: Stroke epidemiology, prevention and management - Chairmen: A. Thrift, A. Ikram

The impact of anticoagulation on stroke associated with atrial ﬁbrillation (W. Hacke, Germany)

When Policy precedes evidence: maximising opportunities to prevent recurrent stroke (A. Thrift, Australia)

Change in the stroke subtypes with dyslipidemia and other risk factors in Japan (Y. Shinohara, Japan)

9:00-10:00 Satellite symposium of the Environmental Neurology Research Group of the World Federation of Neurology

When and how do Environmental factors act on living organisms? (J. Reis, France)

Epigenetic and Environmental Determinants of Taupathies (N. Zawia, USA)

Early life risk factors in Parkinson's disease (G. Logroscino, Italy)

10:00-10:30 Coffee-break and visit of the exhibition and posters area

10:30-11:10 Plenary Session 3: Mild cognitive impairment and dementia - Chairmen: W.A. Rocca, M.M. Mehndiratta

Dementia is more than only cognitive decline: gait patterns as preclinical markers (A. Ikram, The Netherlands)

Sex, gender and Dementia (W.A. Rocca, USA)

11:00-12:00 Room 2 : Satellite symposium: Neuroepidemiology in developing countries - Chairmen: (M-P. Preux, M. Dumas, France)

12:00-13:00 Lunch Break, visit of the exhibition and posters area

13:00-14:40 Plenary Session 4: Disorders of motility - Chairmen: M. AlKaylani, W.A. Rocca

Dimorphic neurology: sex and gender effects in Parkinson’s Disease (W.A. Rocca, USA)

Role of Botulinum Toxin in Oromandibular Dystonia (M. El Tamawy, Egypt)

Update in Genetics of Hereditary Spastic Paraplegia among Arab Peninsula (S. Majid, Saudi Arabia)

Parasomnias and Sleep related movement disorders (M. AlKaylani, UAE)

Cervical artiﬁcial disc placement (K. AlShunnar, UAE)

14:40-16:00 Plenary Session 5: Epilepsy and seizures - Chairmen: K. Mozahem, D. Kömpf

Outcome of epilepsy and prognostic predictors for seizure recurrence after treatment discontinuation (E. Beghi, Italy)

CNS Bugs and stroke (M.M. Mehndiratta, India)

EEG patterns of ictal discharges in focal epilepsy (M. AlKaylani, UAE)

Epilepsy and sleep disorders (K. Mozahem, UAE)

16:00-17:00 Plenary Session 6 - Part 1: General and health economic aspects of neurological disorders - Chairmen : S. Wasti, W. Wang

Population neuro-imaging: history, highlights, future, and challenges (A. Ikram, The Netherlands)

Uncovering the epidemic: ﬁndings on the true incidence of traumatic brain injury (V. Feigin, NZ)

The oculomotor system: signiﬁcant signs in clinical neurology (D. Kömpf, Germany)

Reducing the cumulative burden of Neurodisability on the society (S. Wasti, UAE)

17:00-17:30 Coffee-break and visit of the exhibition and posters area

17:30-18:50 Plenary Session 6 - Part 2: General and health economic aspects of neurological disorders - Chairmen : M. Saada, W. Wang

Brain Death, Towards an Active Diagnosis (M. El Tamawy, Egypt)

Vertigo - a multisensory approach (D. Kömpf, Germany)

Economic implications of not translating evidence: a case study (D. Cadilhac, Australia)

Nationwide stroke epidemiology survey in China: methodological issues (W. Wang, China)

>> Room 2

08:00-09:00 Workshop:

Video session on various movement disorders (A.Q. Rana, Canada)

9:00-10:00 > Neurosurgery * - Chairmen: A. Msaddi, J. Chung

05.144 Robotics in Neurosurgical Stereotactic Interventions- Oblique Intrainsular Electrodes Implanted of Patients with Epilepsy (A. AFIF)

05.262 Intracranial EEG Ictal Onset Frequency- High or Low? (J. Chung)

05.398 Intraoperative Navigation in Spine Surgery (A.K. Msaddi)

05.400 Intrathecal Baclofen Infusion in the Management of Diffuse Spasticity and Dystonia- Challenges in Developing Countries (A.K. Msaddi)

10:00-10:30 Coffee-break and visit of the exhibition and posters area

11:00-12:00 > Satellite symposium: Neuroepidemiology in developing countries - Chairmen: (M-P. Preux, M. Dumas, France)

The Sanoﬁ access to Medicines program in Epilepsy : a contribution of the private sector to reduce the treatment gap (D. Gerard, France)

Domestic health Visits : an innovative approach to increase access to care of people with Epilepsy in Laos and Combodia. (D. Bhalla, India)

Identiﬁcation of people with epilepsy in Ethiopia: Impact of the availability of EEG machine (T-H. Redda, Ethiopia)

12:00-13:00 Lunch Break, visit of the exhibition and posters area

13:00-15:00 > Healthcare > Public Health > Neuropharmacology * - Chairmen: D. Cadilhac, E. Beghi

15.190 The Value Of Retrospective Studies Of End-Of-Life Care For People With Primary Intracranial Tumors- Insight

From Administrative Data (A. Alturki)

15.240 Do patients with stroke enrolled in research studies do better? (D. Cadilhac)

15.286 Knowledge and attitudes towards epilepsy in rural versus urban populations in zambia- a cross-sectional survey (E. Beghi)

15.291 Acute ischemic stroke and sex differences- a population based us study (M. Manoj K.)

17.282 Awareness within the Tunisian population concerning stroke signs, symptoms, and risk factors (S. Ben Amor)

17.293 Migraine headache heritability - twin study (M. Knezevic-Pogancev)

17.369 Home Based Care of Chronic Neurologically Disabled in Kerala, India-A ray of hope for the physician abandoned (U. Syam)

17.403 Reﬂecting the combination of FMF and Multiple Sclerosis- A Case Report (O. Yasemin)

18.368 Quality of life in people with epilepsy on anti-epileptic drugs a hospital based cross sectional study (C. Kulkarni)

15:00-16:30 > Treatment-Management > Ethics * - Chairmen: A.M. Hassa, S. Baeesa

04.203 Pedunculopontine nucleus stimulation in intractable epilepsy- a novel adjunctive therapeutic approach (H. Jaseja)

04.216 First stroke unit in al ain- ﬁve years experience (A.M. Hassan)

04.253 Ethical considerations in neurologic and neuro-oncologic research (D. Suki)

04.301 Alzheimer’s Dementia- A Prospect of Earlier Diagnosis and Treatment (S. Qureshi)

04.304 Vagal Nerve Stimulator Efﬁcacy in the Treatment of Intractable Epilepsy- Experience from Saudi Arabia (S. Baeesa)

04.384 The prophylactic treatment of pulsed electromagnetic ﬁeld (PEMF) in the refractory migraine headache,

double-blind, parallel placebo-controlled study&#1594+ (B. Hatef)

04.444 A randomized double blind non-inferiority study of efﬁcacy, safety and tolerability

of Actorif versus Rebif in patients with Relapsing Remitting MS (M. Nabavi)

16.251 Gipsy origin carries increased risk for cardio-vascular morbidity and mortality in Hungary (G. Szabó)

17:00-17:30 Coffee-break and visit of the exhibition and posters area

17:30-19:30 > Epidemiology * - Chairmen: T. Banerjee, K. Jones

03.151 Post-stroke seizures- data from population-based studies in kolkata, india (T.K. Banerjee)

03.225 The Shanghai Aging Study- Rationale, study design, participation, and baseline characteristics (D. Ding)

03.232 Are strokes in young population getting commoner? (A.M. Hassan)

03.290 Intravenous thrombolysis utilization and mortality after acute ischemic stroke in a population based us study (Manoj K. Mittal M.)

03.334 Stroke Knowledge in Norther India (V.N. Mishra)

03.354 Childhood Traumatic Brain Injury (TBI) in the Community- Child, Clinical and Environmental Predictors of Cognitive,

Behavioural and Quality of Life Outcomes in a New Zealand population-based study (K. Jones)

03.363 Prevalence of dementia in two countries of Central Africa- comparison of rural and urban areas in the EPIDEMCA study (M. Guerchet)

03.397 Multiple sclerosis, vitamin D and meat smoking- a global ecological study (K. Lauer MD)

03.402 Prognostic factors of early death on primary intracerebral hemorrhage the district general hospital

of r. syamsudin sh (dgh-rs) kota sukabumi, 2005-2006 (M. Mangunsong)

03.404 Evaluation of Medical and Educational Services Delivered to Patients with Idiopathic Epilepsy

in Pediatric Neurology Clinic Ain Shams University, Cairo – Egypt (O. El Rashidy)

03.407 Incidence Rate of Intrauterine Growth Restriction and Its Adverse Inﬂuence on Fetal-Neonatal Health- A Report From Mainland China (J. Jing Liu)

* Presenting speakers only. See abstract book for the complete list of authors

SATURDAY NOVEMBER 23, 2013

FINAL SCIENTIFIC PROGRAM

>> Room 1

08:30-09:30 Plenary Session 7: Pain and peripheral nervous system disorders - Chairmen: M. El Tamawy, D. Kayed

Glomus tumor: an atypical and forgettable neurophatic pain, 35 years experience (M. Saadah, UAE)

Alternative headache therapy (D. Kayed, UAE)

Invasive headache therapy (D. Kayed, UAE)

09:30-10:30 Plenary Session 8: Multiple sclerosis - Chairmen: M. Saadah, D. Kömpf

Multiple sclerosis in Asian countries (M. Wasay, Pakistan)

Neurorehabilitation needs of an MS patient (S.Wasti, UAE)

Can psychological stress exacerbate multiple sclerosis? (B. Yamout, Lebanon)

10:30-11:00 Coffee-break and visit of the exhibition and posters area

11:30-12:30 Satellite Symposium: Dementia and Alzheimer’s disease: Prevention, early diagnoses and treatment

Prevention of Alzheimer’s disease: Is it possible? (M. Kivipelto, Sweden)

Early detection of Alzheimer’s disease (N. Andreasen, Sweden)

Alzheimer Disease: Present treatment and research for future targets. (B. Winblad, Sweden)

Health economic evaluation of treatments for AD: impact of new diagnostic criteria (A. Wimo, Sweden)

12:30-13:30 Lunch Break, visit of the exhibition and posters area

13:30-14:30 > Satellite Symposium:

Practice guidelines for the treatment of multiple sclerosis B. Yamout (Lebanon)

Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis A. Shatila (Lebanon)

" Multiple sclerosis: The importance of treatment adherence " B. Yamout (Lebanon)

14:30-15:30 Plenary Session 9: CNS infections and tumours - Chairmen: K. AlShunnar, M. Giroud

Neurobrucellosis at rise of present Millennium (M. Saadah, UAE)

Navigation guided endoscopic transphenoidan pituitary region surgery (K. AlShunnar, UAE)

15:30-16:10 Plenary Session 10: Amyotrophic lateral sclerosis - Chairmen: K. AlShunnar, M. Giroud

Predictors of long-term survival among patients with ALS (E. Beghi, Italy)

16:10-16:40 Coffee-break and visit of the exhibition and posters area

16:40-17:40 Plenary Session 11: Environmental risk factors for neurological disorders - Chairmen: W. Jasim, M. Wasay

Air pollution and stroke incidence (M. Giroud, France)

Vitamin D and stroke prognosis (M. Giroud France)

Cortical Spreading Depolarization (W. Jasim, UAE)

17:40-18:05 Closing remarks and announcements

>> Room 2

08:00-09:00 Workshop:

Using population-based secondary data for neuroepidemiological, health services, and outcomes research

(S.M. Koroukian, USA; Y.F. Glavin, ; Y.Chiou, Taiwan)

9:00-10:30 > Neuropharmacology > Neurorehabilitation > Neuropsychology * - Chairmen: A. Bowirrat, O. Obiako

09.446 A randomized double blind non-inferiority phase III study of efﬁcacy, safety and tolerability of Actovex versus Avonex in patients

with Relapsing Remitting MS (A. Soltanzadeh)

06.103 A model of glial scarring analogous to environment of traumatically injured spinal cord (C. Ho Hwang)

06.254 Stroke Self-Management Rehabilitation Trial (SMART-DVD)- An International, Multi-Site Pilot Trial (K. Jones)

06.455 Analysis of Mental Task Performance and Screening Autism Using Self-Assessment Questionnaire (K. Sasikumar)

06.465 Differential Turning Mechanism Controlled Wheelchair for Quadriplegic Patients Using Head Gesture (R. Kumar)

06.126 Neuro-psychopharmacogenetics and Neurological Antecedents of Post-traumatic Stress Disorder- Unlocking the Mysteries of Resilience

and Vulnerability (A. Bowirrat)

06.208 Perceptions of psychosocial impacts of epilepsy by affected individuals attending Outpatient Epilepsy clinics

in Kaduna State, Northern Nigeria (O. Obiako)

06.431 Cognitive workload evaluation using wavelet packet decomposition (wpd) of eeg (K. Adalarasu)

10:30-11:00 Coffee-break and visit of the exhibition and poster area

11:00-12:30 > Neuroimaging studies > Neuropsychiatry > Health Economics * - Chairmen: M. Di Paola, J. Karn

07.214 Hypoxia and Lesion Tissue Repair in Multiple Sclerosis (P. Narayana)

07.250 Neuroimaging of Hyperacute Ischemic Stroke’s- Post thrombolysis (Atta G. Atta)

07.273 The Digital Brain Library- enabling correlations across neuroimaging and behavioral data in a mixed neurological patient population (A. Jacopo)

07.389 Diffusivity of the Cortical Spinal Tract in Huntington’s disease (M. Di Paola)

07.495 MRI Volumetry Reveals Symmetry of the Trigeminal Nerves in the Mild Neurovascular Conﬂict (D. Horinek)

07.494 Assessment of white matter integrity using diffusion tensor imaging in Marchiafava-Bignami disease with cortical involvement- case report

and review of literature (P.P. Zhao)

07.496 Acute disseminated encephalomyelitis with peripheral nervous system involvement. in an adult following meales (P.P. Zhao)

07.359 The cost of traumatic brain injury in new zealand- evidence from a population based study (B. Te Ao)

07.376 The impact of Warfarin and Clinical Factors on Acute Hospital and First Year Treatment Costs of Intracerebral Haemorrhage (J. Kam)

12:30-13:30 Lunch Break, visit of the exhibition and poster area

14:00-15:10 > Epidemiology * - Chaimen: O. Ogunrin, Y. Winter

03.159 Risk factors for epilepsy in Nigerian Africans – a case control study (O. Olubunmi)

03.168 Total and LDL cholesterol as risk factor of ischemic stroke in Emirati patients (T. Zein)

03.186 Incidence of neuroborreliosis-associated cerebral vasculitis in Germany (Y. Winter)

03.237 Indonesia Stroke Registry (Y. Fenny)

03.242 Life-style associated risk factors of amyotrophic lateral sclerosis - First results from a case-control study conducted in the ALS Register Swabia (G. Nagel)

03.252 Increase in the frequency of brain metastases in pediatric cancer patients- fact or fallacy? (D. Suki)

15:10-16:10 > Epidemiology * - Chairmen: S. Koroukian, A. Abdulnayef

03.261 Incidence and prevalence of epilepsy in low-income populations- is it also elevated in a single-payer system? (S. Koroukian)

03.267 Prevalence of dementia in Lebanon- Preliminary data from Beirut, Shouf, and Aley (T.K.T. Phung)

03.314 Meta-analyses to investigate gene-environment interactions in neuroepidemiology (I. Van der Mei)

03.421 Sleep Disturbances in Paraplegics within a Large Urban Community- Prevalence and Associated Co-morbidities (M. Bul Bul, A. Nasif)

03.426 Sleep apnea (apnoea) epidemyology diagnosis and management. dr. abdulnayef azhar, neurologist, departement of neurology,

lariboisière hospital, paris, france dr. shekh omar talal, cardiologist, departement of cardiology, clinique de l’estree (A. Abdulnayef)

03.173 Epidemiology and distribution of huntington’s disease in slovenia (J. Kobal)

16:10-16:40 Coffee-break and visit of the exhibition and poster area

* Presenting speakers only. See abstract book for the complete list of authors

Poster Title Authors Name & Surname

01/ Prevention > Presenting speakers only. See abstract book for the complete list of authors

1.205 Patterns of multifocal atherosclerosis revealed by duplex ultrasound in cross-sectional population based study (M. Kravchenko)

1.221 Incidence of urinary tract infection among patients with acute cerebrovascular accidents- A possible trigger for stroke (J. Kuruvilla)

1.222 women issues in multiple sclerosis (S. Noori)

1.227 Electrosensitivity from a neurological point of view (M. Griesz-Brisson)

1.275 Metrics of vagal nerve stimulator surgery (N. Moufarrij)

1.371 Management shoulder syndrome associated with Parkinson’s disease (Y. özkan)

1.411 Microembolic signals in the symptomatic and asymptomatic middle cerebral artery stenosis (W. Xiujuan)

1.484 The study of cerebral autoregulation in patients with severe carotid artery stenosis or occlusions (X. Yingqi)

02/ Diagnosis > Presenting speakers only. See abstract book for the complete list of authors

2.137 A new technique for automatic pruning and detection of epileptic spikes using discrete wavelet transform (K.P. Indiradevi)

2.167 Problems in the assessment of diagnostic test validity of already established biomarkers – a simulation study using the example of 14-3-3

in sporadic Creutzfeldt-Jakob disease (A. Karch)

2.231 Cerebrovascular reactivity to l-arginine in subjects with ischemic leukoaraiosis (J. Kobal)

2.263 Cerebral venous sinus thrombosis, pitfalls and challenges (H. Al-Jehani)

2.283 Diabetic Polyneuropathy Versus Diabetic Chronic Inﬂammatory Demyelinating Polyneuropathy+ Clinical, Laboratory

and Electrophysiological Study (E. Shawki)

2.323 Clinical and radiological proﬁle of basal ganglia encephalitis in children (K. Mohamed)

2.373 Seizures wihtout awareness- patient proﬁles and outcomes (M. Langston)

2.437 A simple method to determine whole body vibration induced reﬂex latency (H.I. Cakar)

2.449 Report of two cases with occult cervical spinal dysraphism and scoliosis (C. Muharrem)

2.481 Periodic changes of the pulsatility index of the cerebral artery by transcranial Doppler sonography as a clue

for leptomeningeal carcinoma- a report of two cases (W. Xiujuan)

2.483 A comparison of transcranial Doppler, transthoracic echocardiography, and transesophageal echocardiography in the diagnosis

of Patent Foramen Ovale (L. Kangding)

03/ Epidemiology > Presenting speakers only. See abstract book for the complete list of authors

3.158 Etiologies of epilepsy and health-seeking itinerary of patients with epilepsy in a resource poor setting- analysis

of 342 Nigerian Africans (O. Olubunmi)

3.161 Prevalence of stroke in Lebanon- A 2012 cross-sectional study (N. Lahoud)

3.210 Stroke Registers in Russia (Y. Varakin)

3.217 Seasonal ﬂuctuations of stroke in Armenia (L. Gimoyan)

3.248 Autoimmune comorbidity in Multiple sclerosis (M. Melinda Magyari)

3.258 Neurologic morbidity and quality of life in long-term survivors of childhood acute lymphoblastic leukemia (R. Khan)

3.264 A community study of prevalence of primary headaches in the city of Kolkata, India (S. Das)

3.268 Comparative study of complexity analysis of epileptic scalp eeg records (K.P. Indiradevi)

3.289 Prevalence and incidence of epilepsy in Italy based on a nationwide database (E. Beghi)

3.300 Sudden unexplained death in Epilepsy(SUDEP) (S. Qureshi)

3.313 Effects of adjunct 25-hydroxyvitamin D on retinal nerve ﬁber layer in patient with optic neuritis- Preliminary ﬁndings of a randomized,

placebo-controlled trial (M. Janghorbani)

3.360 Stroke Registers in Russia (Y. Varakin)

3.386 Stroke subtypes and frequency of carotid stenoses in patients with ischemic stroke (K. Dragutin)

3.412 Proﬁle of dementia and cognitive impairment non-dementia in memory clinic of Cipto Mangunkusumo Hospital, Indonesia (S. Lumempouw)

3.466 The pattern of epilepsy among Yemeni patients (A. Abdulrab)

POSTERS

FINAL SCIENTIFIC PROGRAM

3.470 Risk factors of vitamin d deﬁciency in patients with widespread musculoskeletal pain (C. Muharrem)

3.489 Risk factors and microbiological data of stroke-associated pneumonia in Neurological Intensive Care Unit in China (Y. Xing)

04/ Treatment-Management > Presenting speakers only. See abstract book for the complete list of authors

4.179 Incidence of lupus anticoagulants in ﬁrst time TIA (R. Ram Chettiar)

4.191 Successful treatment of syndrome of artery of Percheron (R. Chettiar)

4.202 Stroke and poblational-neurological centers studies-crossed nested case-controls the nedices

and netherlands stroke survey (S.G. Echebarria Mendieta)

4.219 women issues in Multiple sclerosis (S. Noori)

4.241 Relationship between options of original ambulatory blood-pressure monitoring of patients with non-complicated arterial hypertension

of 1 – 2 stage and dynamics of memory disorders under the inﬂuence of antihypertensive treatment (A. Kadykov)

4.246 Factors Inﬂuencing Response to Corticosteroid in Chronic Inﬂammatory Demyelinating Polyradiculoneuropathy (S. Je-Young)

4.255 Transcranial Doppler in Neurological extremes, what can we learn? (H. Al-Jehani)

4.257 Early abnormal transient hyperemic response test can help predict delayed ischemic neurologic deﬁcit in subarachnoid hemorrhage (H. Al-Jehani)

4.292 Myasthenia gravis- thymectomy and quality of life (Y. Bykov)

4.327 Patients’ knowledge and attitudes toward treatment and control of hypertension- a questionnaire survey in japanese elderly subjects (N. Fumitoshi)

4.358 Analysis of recurrence risk factors after antiepileptic drug withdrawal in 173 patients (H. Zhen)

4.387 Tumor like Presentation of CNS Tuberculosis- A Retrospective Study from Saudi Arabia (H. Algahtani)

4.415 Cerebral reactivity and initial orthostatic hypotension during active orthostatic test in patients

with essential hypertension and cerebrovascular disease (E. Oshchepkova)

4.416 Types of initial orthostatic reactions during active orthostatic test in patients with essential hypertension (E. Oshchepkova)

4.417 Quality of life in patients with ms and d v&#304+tam&#304+n level (Y. özkan)

05/ Neurosurgery > Presenting speakers only. See abstract book for the complete list of authors

5.209 Outcome of Temporal Lobectomy for Intractable Epilepsy- Experience from Single Epilepsy Center in Saudi Arabia (S. Baeesa)

5.243 Tissue oxygen measurement for patients with severe brain injury as a part of multimodal monitoring (R. Ga)

5.249 Neonates with disease states that are characterized by increased levels of corticoids may be especially vulnerable

to the developmental effects of general anesthesia (A. Martynyuk)

5.280 Evaluation of frameless deep brain stimulation (N. Moufarrij)

5.302 Detection of glioblastoma brain tumor cells using SpectroPen (S. Abhinav)

5.315 CSF phosphorylated neuroﬁlament subunit NF-H (pNF-H) levels are predictor of outcome in Spinal Cord Injury (S.M. Iencean)

5.346 Diagnosis and treatment of normal pressure hydrocephalus in elderly patients (J.D. Patet)

5.356 Novel training course of neuroresuscitation for neurosurgeon in Japan. - Primary Neurosurgical Life Support Course (M. Takahashi)

5.399 Neuro-Stimulation in the Management of Neuropathic Pain (A.K. Msaddi)

5.438 Videoendoscopic transpedicular cord decompression in complicated thoraco-lumbar spine trauma (O. Krotenkova)

5.439 Microsurgery for degenerative thoracic spine disease- comparative analysis with conventional surgical thechniques (O. Krotenkova)

5.485 Risk factors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis therapy (Y. Xing)

06/ Neurorehabilitation > Presenting speakers only. See abstract book for the complete list of authors

6.104 Effects of erythropoietin on glial scar formation and axonal outgrowth in a traumatically injured spinal cord model (C. Ho Hwang)

6.218 An analysis of length of stay in different neurological disorders patients in Saudi Arabia (M. Al-Jadid)

6.269 Reliability and responsiveness of the greek version of the stroke-speciﬁc quality of life questionnaire (ssqol-gr)- a pilot study (E. Kapreli)

6.441 Postoperative rehabilitation in patients with discogenic thoracic myelopathy (O. Krotenkova)

07/ Etudes de neuroimagerie > Presenting speakers only. See abstract book for the complete list of authors

7.143 Deﬁnition of a Stereotactic 3d Model of the Human Insula for Neurosurgical Approach (epilepsy and Stereotaxic Surgery) (A. AFIF)

7.176 Prevalence of unruptured aneurysm in patients with migraine (K. Manho)

7.177 Corpus Callosum changes predict pathology progression in Alzheimer’s Disease (M. Di Paola)

7.178 Selective cognitive dysfunction in TBI patients is related to a selective cerebral damage’s pattern (M. Di Paola)

7.332 UP, UP, and away- a jounrey through the skull base (S. Patel)

7.388 Iron Content in the Cortical Spinal Tract in Huntington’s disease (M. Di Paola)

7.440 MRI differential diagnosis of the thoracic disc herniation (O. Krotenkova)

7.462 Somatosensory Evoked Potential Abnormalities in Ankylosing Spondylitis- Their relation to Clinical Findings (C. Muharrem)

7.228 Testosterone treatment increases cerebral gray matter in multiple sclerosis (E. Luders)

08/ Neurogenetics > Presenting speakers only. See abstract book for the complete list of authors

8.123 Genetic and Environmental risk factors for Neurodegenerative Diseases among Arab Population (A. Bowirrat)

09/ Neuropharmacology > Presenting speakers only. See abstract book for the complete list of authors

9.171 Effect of Ocimum basilicum extract against pentylenetetrazole-induced seizure in mice (M. Modaresi)

10/ Neuropsychology > Presenting speakers only. See abstract book for the complete list of authors

10.125 Whole-Body Vibration Induced Reﬂex Muscle Activity Latency and Tonic Vibration Reﬂex (S.S. Karamehmetoglu)

10.160 Cognitive effects of anti-epileptic drugs in nigerians with epilepsy (O. Olubunmi)

10.487 Use of transcranial Doppler in the assessment of cerebrovascular modulation in anxiety (Y. Yang)

11/ Neuropsychiatrie > Presenting speakers only. See abstract book for the complete list of authors

11.266 The Rate of Consanguineous Marriages Among the Parents of Schizophrenic Patients in the Arab Bedouin Population in Southern Israel (R.H. Belmaker)

11.408 Excessive daytime sleepiness in obese patients+ A case-control study (P. Zarghamravanbakhsh)

11.351 Levodopa therapy and depression in Parkinson’s disease (Z. Tavadyan)

12/ Base et Traduction > Presenting speakers only. See abstract book for the complete list of authors

12.265 Cross-cultural adaptation and validation of the stroke-speciﬁc quality of life questionnaire (ssqol)- greek version (N. Strimpakos)

12.365 Idiopathic scoliosis - expression of estrogen receptor 2 and ﬁber type distribution in biopsies of deep paravertebral muscles (J. Zamecnik)

15/ Health > Presenting speakers only. See abstract book for the complete list of authors

15.215 A review of parkinson’s disease in sub-saharan africa (E. Gibbons)

15.480 Evaluation of clinical aspects and quality of life as risk factors for depression in patients with epilepsy (Y. Peimin)

17/ Public health > Presenting speakers only. See abstract book for the complete list of authors

17.169 Epilepsy- Stigma and Management from Pakistan’s Perspective (R. Naz)

17.393 Female patients with multiple sclerosis showed increase levels of C21 neuroative steroids (L. Kancheva)

17.427 Can we measure the level of pre-hospital care by a medical rally? (H. Ikeda)

17.480 Development of Guillain-Barré syndrome in patients receiving ganglioside treatment (L. Kangding)

18/ Neuropharmacology > Presenting speakers only. See abstract book for the complete list of authors

18.226 Should We Consider Intravenous Levetiracetam an Alternative to Old Anticonvulsants in Acute Seizure Management

in Neonates and Children? (B. Kirmani)

Notes

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GENERAL INFORMATION

FINAL SCIENTIFIC PROGRAM

> Conference Venue

Jumeirah Etihad Towers Hotels

West Corniche Pox Box 111929, Abu Dhabi - Tel:+9718115555

> Welcome Desk

Thursday November 21th: 8:00 - 19:30

Friday November 22nd: 6:30 - 19:30

Saturday November 23rd: 8:00 - 18:15

> CME Accreditation

European Accreditation Council for Continuing Medical Education (UEMS/EACCME)

ICNE 2013 is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide

the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical

Specialists (UEMS): www.uems.net

ICNE 2013 was granted 17 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medi-

cal Education (EACCME). Each medical specialist should claim only those hours of credit that he/she actually spent

in the educational activity.

The UEMS-EACCME has mutual recognition agreements with:

American Medical Association (AMA)

Through an agreement between the European Union of Medical Specialists and the American Medical Association,

physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the

process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Health Auhority - Abu Dhabi (HAAD)

HAAD recognizes the European Accreditation Council for Continuing Medical Education as an “equivalent” Accre-

diting Organisation. That is, participants to events accredited by a recognized bodie can count the CE for Category

1 credit hours, just as they would if they had attended a HAAD-accredited event. Visit: http://www.haad.ae/cme/

Accreditation/AccreditationEquivalency.aspx

Royal College of Physicians and Surgeons of Canada

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are dee-

med to be Accredited Group Learning Activities (Section 1) as deﬁned by the Maintenance of Certiﬁcation Program of

The Royal College of Physicians and Surgeons of Canada. For more information, visit: www.royalcollege.ca.

EXHIBITION PLAN

FINAL SCIENTIFIC PROGRAM

European Accreditation Council for Continuing Medical Education (UEMS/EACCME)

ICNE 2013 is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide

the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical

Specialists (UEMS): www.uems.net

ICNE 2013 was granted 17 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medi-

cal Education (EACCME). Each medical specialist should claim only those hours of credit that he/she actually spent

in the educational activity.

The UEMS-EACCME has mutual recognition agreements with:

American Medical Association (AMA)

Through an agreement between the European Union of Medical Specialists and the American Medical Association,

physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the

process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Health Auhority - Abu Dhabi (HAAD)

HAAD recognizes the European Accreditation Council for Continuing Medical Education as an “equivalent” Accre-

diting Organisation. That is, participants to events accredited by a recognized bodie can count the CE for Category

1 credit hours, just as they would if they had attended a HAAD-accredited event. Visit: http://www.haad.ae/cme/

Accreditation/AccreditationEquivalency.aspx

Royal College of Physicians and Surgeons of Canada

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are dee-

med to be Accredited Group Learning Activities (Section 1) as deﬁned by the Maintenance of Certiﬁcation Program of

The Royal College of Physicians and Surgeons of Canada. For more information, visit: www.royalcollege.ca.

> Stand 1 Sanoﬁ Aventis

> Stand 2 Newbridge Pharmaceuticals

> Stand 3 Merck Serono

PARTNERS ACKNOWLEDGEMENTS

FINAL SCIENTIFIC PROGRAM

The International Conference on Neurology & Epidemiology

would like to thank the following for their support:

GOLD Sponsors

SILVER Sponsors

Notes

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ORGANIZATION

EVENTIME

9 rue Gustave Ricard - 13006 Marseille

Tél. : +33 (4) 95 05 30 67 - Fax : +33 (4) 91 58 54 94

contact@eventime-group.com

The prophylactic treatment of pulsed electromagnetic field (PEMF) in the refractory migraine headache, double-blind, parallel placebo-controlled study

Recommended publications

The efficiency of pulsed electromagnetic field in refractory migraine headaches: a randomized, singl...

The Prophylactic Treatment of PEMF in the Refractory Migraine Headache, Double-Blind, Parallel Place...

The prophylaction treatment of PEMF in the refactory migraine headache, double-blind, parallel palce...

Timing Pattern of Masseter Muscle Activity During the Open-Close-Clench Cycle in Women with Tension...